Summary of Anti-Dumping Investigation: ACE Inhibitors From Germany and Switzerland
[ Last Updated 26 January 2006 ]
Description of Goods:
Angiotensin converting enzyme (ACE) inhibitors made with the active ingredient cilazapril or quinapril, other than combination ACE inhibitors
Countries of Origin:
Germany and Switzerland
History of Determination:
| Initiated: | 8 April 1999 |
| Termination: | 30 August 1999 |
Introduction:
Merck Sharp & Dohme (Australia) Pty Ltd, part of the Australian industry, alleged that ace inhibitors from Germany and Switzerland were threatening to cause material injury. Another Australian producer, Bristol Meyers Squibb (Australia) Pty Ltd, also supported the application.
Anti-dumping Duty:
Not applicable - Investigation terminated
Notes:
Overview
The investigation was terminated by the Minister for Enterprise and Commerce pursuant to section 11(1) of the Dumping and Countervailing Duties Act. This provides that the Minister shall terminate an investigation if he is satisfied that:
(a) The application for the investigation has been withdrawn in writing by those Australian producers by or on whose behalf the application was made; or
(b) Australian producers who previously expressed support for the application for the investigation have withdrawn that support to such an extent that the "standing" requirements for initiation could no longer be met.
The Minister terminated the investigation because the application was withdrawn in writing by Merck Sharp & Dohme (Australia) Pty Ltd and Bristol Meyers Squibb (Australia) Pty Ltd.
The termination report is available here.
Further Information:
Should there be any further information required or if there are any queries please contact the Trade Remedies Group on telephone 04-472-0030 or facsimile 04-499-8508. Inquiries by e-mail should be directed to traderem@med.govt.nz
Back to Top